| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acceptance and uptake of influenza vaccines in Asia: A systematic review
|
Sheldenkar, Anita
|
|
|
37 |
35 |
p. 4896-4905
|
artikel
|
| 2 |
A novel method for performing antigenic vaccine matching for foot-and-mouth disease in absence of the homologous virus
|
Sirdar, Mohamed M.
|
|
|
37 |
35 |
p. 5025-5034
|
artikel
|
| 3 |
Case report: Recurrent peripheral facial paralysis following two influenza vaccinations in 2009 and 2016
|
Gocko, Xavier
|
|
|
37 |
35 |
p. 4864-4866
|
artikel
|
| 4 |
Challenges with hepatitis B vaccination of high risk adults – A pilot program
|
Bridges, Carolyn B.
|
|
|
37 |
35 |
p. 5111-5120
|
artikel
|
| 5 |
Commentary: Embracing social sciences to improve population health
|
Butler, Robb
|
|
|
37 |
35 |
p. 4835-4837
|
artikel
|
| 6 |
Convening on the influenza human viral challenge model for universal influenza vaccines, Part 2: Methodologic considerations
|
Innis, Bruce L.
|
|
|
37 |
35 |
p. 4830-4834
|
artikel
|
| 7 |
Cost-effectiveness analysis of the implementation of a National Immunization Program for rotavirus vaccination in a country with a low rotavirus gastroenteritis-related mortality: A South Korean study
|
Lee, Hankil
|
|
|
37 |
35 |
p. 4987-4995
|
artikel
|
| 8 |
Cost-effectiveness of meningococcal polysaccharide serogroups A, C, W-135 and Y conjugate vaccine in Australian adolescents
|
Si, Si
|
|
|
37 |
35 |
p. 5009-5015
|
artikel
|
| 9 |
Dengue vaccine: WHO position paper, September 2018 – Recommendations
|
|
|
|
37 |
35 |
p. 4848-4849
|
artikel
|
| 10 |
Duration of immunity in recipients of two doses of 17DD yellow fever vaccine
|
|
|
|
37 |
35 |
p. 5129-5135
|
artikel
|
| 11 |
Editorial Board/Aims and Scope
|
|
|
|
37 |
35 |
p. IFC
|
artikel
|
| 12 |
Effective mosaic-based nanovaccines against avian influenza in poultry
|
Kingstad-Bakke, Brock A.
|
|
|
37 |
35 |
p. 5051-5058
|
artikel
|
| 13 |
Estimating the effect of measles vaccination on child growth using 191 DHS from 65 low- and middle-income countries
|
Bogler, Lisa
|
|
|
37 |
35 |
p. 5073-5088
|
artikel
|
| 14 |
Exploring the effects of BCG vaccination in patients diagnosed with tuberculosis: Observational study using the Enhanced Tuberculosis Surveillance system
|
Abbott, Sam
|
|
|
37 |
35 |
p. 5067-5072
|
artikel
|
| 15 |
Hepatitis B surface antigen seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017
|
Ork, Vichit
|
|
|
37 |
35 |
p. 5059-5066
|
artikel
|
| 16 |
Hepatitis B vaccine coverage in short and long stay prisons in Wales, UK 2013–2017 and the impact of the global vaccine shortage
|
Perrett, Stephanie E.
|
|
|
37 |
35 |
p. 4872-4876
|
artikel
|
| 17 |
Immunogenicity of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) administered concomitantly with the meningococcal serogroup B (4CMenB) vaccine in infants: A post-hoc analysis in a phase 3b, randomised, controlled trial
|
Safadi, Marco Aurelio P.
|
|
|
37 |
35 |
p. 4858-4863
|
artikel
|
| 18 |
Impact of maternally derived antibodies to Plasmodium falciparum Schizont Egress Antigen-1 on the endogenous production of anti-PfSEA-1 in offspring
|
Park, Sangshin
|
|
|
37 |
35 |
p. 5044-5050
|
artikel
|
| 19 |
Impact of vaccine stockouts on immunization coverage in Nigeria
|
Gooding, Emily
|
|
|
37 |
35 |
p. 5104-5110
|
artikel
|
| 20 |
Italian midwives and influenza vaccination: problems in adherence and perception
|
Belingheri, Michael
|
|
|
37 |
35 |
p. 4851
|
artikel
|
| 21 |
Meeting report: Convening on the influenza human viral challenge model for universal influenza vaccines, Part 1: Value; challenge virus selection; regulatory, industry and ethical considerations; increasing standardization, access and capacity
|
Innis, Bruce L.
|
|
|
37 |
35 |
p. 4823-4829
|
artikel
|
| 22 |
Models to predict the public health impact of vaccine resistance: A systematic review
|
Reid, Molly C.
|
|
|
37 |
35 |
p. 4886-4895
|
artikel
|
| 23 |
Nephrotic syndrome following four-component meningococcal B vaccination: Epidemiologic investigation of a surveillance signal
|
De Serres, Gaston
|
|
|
37 |
35 |
p. 4996-5002
|
artikel
|
| 24 |
Newcastle disease virus vectors expressing consensus sequence of the H7 HA protein protect broiler chickens and turkeys against highly pathogenic H7N8 virus
|
Roy Chowdhury, Ishita
|
|
|
37 |
35 |
p. 4956-4962
|
artikel
|
| 25 |
Novel colloidal associations of soyasaponins and lipid components (DPPC, cholesterol) as potential adjuvants for vaccines
|
de Groot, Carolin
|
|
|
37 |
35 |
p. 4975-4986
|
artikel
|
| 26 |
Perceptions of politicization and HPV vaccine policy support
|
Saulsberry, Loren
|
|
|
37 |
35 |
p. 5121-5128
|
artikel
|
| 27 |
Persistence of immunity to conjugate and polysaccharide pneumococcal vaccines in frail, hospitalised older adults in long-term follow up
|
MacIntyre, C. Raina
|
|
|
37 |
35 |
p. 5016-5024
|
artikel
|
| 28 |
Pneumococcal carriage among adults aged 50 years and older with co-morbidities attending medical practices in Rome, Italy
|
Valdarchi, Catia
|
|
|
37 |
35 |
p. 5096-5103
|
artikel
|
| 29 |
Political will and vaccine legislation
|
Berkley, Seth
|
|
|
37 |
35 |
p. 4838-4839
|
artikel
|
| 30 |
Randomized study of immune responses to two Tdap vaccines among adolescents primed with DTaP and comparison with results among adolescents primed with DTwP
|
Decker, Michael D.
|
|
|
37 |
35 |
p. 5003-5008
|
artikel
|
| 31 |
Response to Morimoto and Takeishi 2018
|
Mallory, Raburn M.
|
|
|
37 |
35 |
p. 4852
|
artikel
|
| 32 |
Rethinking results from the Japanese 23-valent pneumococcal polysaccharide vaccine randomized clinical trial
|
Gessner, Bradford D.
|
|
|
37 |
35 |
p. 4853-4857
|
artikel
|
| 33 |
Strengthening legal frameworks for vaccination: The experiences of Armenia, Georgia, and Moldova
|
Trumbo, Silas P.
|
|
|
37 |
35 |
p. 4840-4847
|
artikel
|
| 34 |
Syngeneic B16-F1 cells are more efficient than allogeneic Cloudman cells as antigen source in DC-based vaccination in the B16-F1 murine melanoma model
|
Mac Keon, Soledad
|
|
|
37 |
35 |
p. 4947-4955
|
artikel
|
| 35 |
Temporal trends in anti-vaccine discourse on Twitter
|
Gunaratne, Keith
|
|
|
37 |
35 |
p. 4867-4871
|
artikel
|
| 36 |
The Global Vaccine Action Plan – insights into its utility, application, and ways to strengthen future plans
|
Daugherty, Michael A.
|
|
|
37 |
35 |
p. 4928-4936
|
artikel
|
| 37 |
The partnership for influenza vaccine introduction (PIVI): Supporting influenza vaccine program development in low and middle-income countries through public-private partnerships
|
Bresee, Joseph S.
|
|
|
37 |
35 |
p. 5089-5095
|
artikel
|
| 38 |
The prevention of cholera in the Bible
|
Mazokopakis, Elias E.
|
|
|
37 |
35 |
p. 4850
|
artikel
|
| 39 |
Therapeutic vaccines for amyotrophic lateral sclerosis directed against disease specific epitopes of superoxide dismutase 1
|
Zhao, Beibei
|
|
|
37 |
35 |
p. 4920-4927
|
artikel
|
| 40 |
The STING activator c-di-AMP exerts superior adjuvant properties than the formulation poly(I:C)/CpG after subcutaneous vaccination with soluble protein antigen or DEC-205-mediated antigen targeting to dendritic cells
|
Volckmar, Julia
|
|
|
37 |
35 |
p. 4963-4974
|
artikel
|
| 41 |
Uptake and spread of infectious laryngotracheitis vaccine virus within meat chicken flocks following drinking water vaccination
|
Groves, Peter J.
|
|
|
37 |
35 |
p. 5035-5043
|
artikel
|
| 42 |
UTI patients have pre-existing antigen-specific antibody titers against UTI vaccine antigens
|
Sarkissian, Christina A.
|
|
|
37 |
35 |
p. 4937-4946
|
artikel
|
| 43 |
Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries
|
Madeddu, Giordano
|
|
|
37 |
35 |
p. 4906-4919
|
artikel
|
| 44 |
Vaccines for maternal immunization against Group B Streptococcus disease: WHO perspectives on case ascertainment and case definitions
|
Seale, Anna C.
|
|
|
37 |
35 |
p. 4877-4885
|
artikel
|
Tijdschrift beschrijving